Invention Grant
- Patent Title: Benzotriazole derivatives as modulators of TNF activity
-
Application No.: US15101073Application Date: 2014-12-08
-
Publication No.: US09957255B2Publication Date: 2018-05-01
- Inventor: Daniel Christopher Brookings , Boris Kroeplien
- Applicant: UCB BIOPHARMA SPRL
- Applicant Address: BE Brussels
- Assignee: UCB BIOPHARMA SPRL
- Current Assignee: UCB BIOPHARMA SPRL
- Current Assignee Address: BE Brussels
- Priority: GB1321740.1 20131209
- International Application: PCT/EP2014/076847 WO 20141208
- International Announcement: WO2015/086508 WO 20150618
- Main IPC: C07D403/04
- IPC: C07D403/04 ; C07D413/14 ; C07D413/04 ; C07D249/18 ; A61K31/506 ; A61K31/5377
Abstract:
A series of substituted benzotriazole derivatives, being potent modulators of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
Public/Granted literature
- US20160297799A1 Benzotriazole Derivatives as Modulators of TNF Activity Public/Granted day:2016-10-13
Information query
